CFD
COLL icon

Creative Financial Designs’s Collegium Pharmaceutical COLL Stock Holding History

Creative Financial Designs’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-350
Closed -$16.2K – 2177
2025
Q4 		$16.2K Hold
350
– – ﹤0.01% 1211
2025
Q3 		$12.2K Hold
350
– – ﹤0.01% 1308
2025
Q2 		$10.3K Buy
+350
New +$9.98K ﹤0.01% 1336
2021
Q3 		– Sell
-100
Closed -$2K – 1395
2021
Q2 		$2K Buy
+100
New +$2.31K ﹤0.01% 1311

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Creative Financial Designs's COLL Position: Q1 2026 in Review

Creative Financial Designs sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 350 shares — an estimated $16.2K sold.

Creative Financial Designs first reported a position in COLL in Q2 2021 and held it in 4 quarters. The position peaked at $16.2K in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Creative Financial Designs reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Creative Financial Designs sold 350 Collegium Pharmaceutical shares in Q1 2026, an estimated $16.2K.
  • Creative Financial Designs first reported a position in Collegium Pharmaceutical in Q2 2021 and held it in 4 quarters.
  • Creative Financial Designs's Collegium Pharmaceutical position peaked at $16.2K in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.